| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | See Remarks | Chief Financial Officer
1 company
Notman Donald is a Chief Operating Officer at OCUL. Recent filings cover 3 purchases and 10 sales. Those positions are worth an estimated $3.8M at current prices.
Our model assigns Notman Donald a below-average insider score of 35/100, based on 6 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -32.9%.
Notman Donald's largest disclosed position is in OCUL as Chief Operating Officer, worth about $3.8M. The recent filings there lean toward selling, a net 41,842 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | OCUL Ocular Therapeutix, Inc. | Chief Operating Officer | Sell | 1,099 | $10.24 | $11,253.76 | -0.3% | - | - | |
| Feb 12, 2026 | OCUL Ocular Therapeutix, Inc. | Chief Operating Officer | Sell | 11,446 | $9.04 | $103,471.84 | -3.0% | +2.0% | - | |
| Feb 4, 2026 | OCUL Ocular Therapeutix, Inc. | Chief Operating Officer | Sell | 11,490 | $8.82 | $101,397.60 | -3.0% | +13.6% | - | |
| Sep 2, 2025 | OCUL Ocular Therapeutix, Inc | See Remarks | Sell | 1,066 | $12.43 | $13,250.38 | -0.3% | -7.8% | -14.2% | |
| Feb 4, 2025 | OCUL Ocular Therapeutix, Inc | See Remarks | Sell | 17,420 | $7.82 | $136,239.23 | -8.3% | -1.2% | +9.3% | |
| Feb 5, 2024 | OCUL Ocular Therapeutix, Inc | Chief Financial Officer | Sell | 6,212 | $4.86 | $30,190.32 | -3.1% | +17.2% | +58.0% | |
| Jan 31, 2024 | OCUL Ocular Therapeutix, Inc | Chief Financial Officer | Sell | 6,433 | $4.95 | $31,843.35 | -4.4% | -2.5% | +60.1% | |
| Feb 6, 2023 | OCUL Ocular Therapeutix, Inc | Chief Financial Officer | Sell | 6,476 | $4.24 | $27,458.24 | -4.4% | +50.6% | +18.6% | |
| Jun 14, 2019 | OCUL Ocular Therapeutix, Inc | Chief Financial Officer | Buy | 2,500 | $4.33 | $10,825.00 | +11.6% | - | - | |
| Aug 14, 2018 | OCUL Ocular Therapeutix, Inc | Chief Financial Officer | Buy | 12,500 | $6.29 | $78,625.00 | +260.4% | - | - |